pfizer sells capsule unit to k.k.r.
the $2.375 billion deal may be a harbinger amid speculation that pfizer will sell or spin off its nonpharmaceutical businesses.
http://feeds.nytimes.com/click.phdo?i=b9ab2252f05eb941a94d74f16e68abdf
12222
04 Apr 2011 17:53:03
nyt
business